Browse studies, page 1161

Page 1161 of 1,203, newest first. Search them all at once, ranked by relevance, in Evidence Hub.

• Comparative efficacy of ceftolozane-tazobactam versus ceftazidime-avibactam for Pseudomonas aeruginosa infections: a GRADE-assessed systematic review and meta-analysis Annals of medicine and surgery (2012), 2026
• Evaluating the effectiveness and safety of Xiyanping injection for severe pneumonia: a target trial emulation protocol using real-world data Frontiers in Pharmacology, 2026
• The Therapeutic Efficacy of Abatacept for Rheumatoid Arthritis-Associated Interstitial Lung Disease: Insights from a 12-Month Trial Using Semi-Quantitative Chest High-Resolution Computed Tomography Imaging Journal of Clinical Medicine, 2024
• Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trial Contemporary Clinical Trials, 2023
• A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study) Clinical Infectious Diseases, 2020
• Efficacy and safety of SMET12 in combination with toripalimab and chemotherapy in advanced non-small-cell lung cancer patients tested positive for EGFR protein who are treatment-naïve or harbor acquired resistance to standard therapy: a phase 2, multi-cohort clinical trial Frontiers in Immunology, 2026
• Results of a Double-Blind Prospective Comparative Randomized Phase 3 Clinical Trial of the Efficacy and Safety of BCD-264 and Darzalex as Monotherapy for Relapsed/Refractory Multiple Myeloma (BCD-264-2/DARVIVA) Clinical oncohematology, 2026
• Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial Journal of the American Medical Association (JAMA), 2019
• Preliminary efficacy and safety of camrelizumab combined with cetuximab and chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): A phase II clinical trial Journal of Clinical Oncology, 2024
• Effectiveness of Hyperbaric Oxygen Therapy in SARS-CoV-2 Pneumonia: The Primary Results of a Randomised Clinical Trial Journal of Clinical Medicine, 2022
• Clinical study on modified Shenzhe Zhenqi Decoction combined with ambroxol hydrochloride in the treatment of severe pneumonia Frontiers in Physiology, 2025
• Efficacy and safety of RP1 combined with nivolumab in patients with anti–PD-1–failed melanoma from the IGNYTE clinical trial Journal of Clinical Oncology, 2024
• Severe Pneumonia Management and Bronchoalveolar Lavage Efficacy in Yunnan's Ethnic Minorities MEDS Clinical Medicine, 2024
• Probiotic prophylaxis to prevent ventilator-associated pneumonia in children on mechanical ventilation: A randomized double-blind clinical trial Frontiers in Pediatrics, 2022
• Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies BioScience Trends, 2020
• Ivermectin and outcomes from Covid‐19 pneumonia: A systematic review and meta‐analysis of randomized clinical trial studies Reviews in Medical Virology, 2021
• Clinical Efficacy of The Postbiotic Drug Biodonatum In Children with Pneumonia and Reduced Sensitivity to Antibiotic Therapy International journal of medical science and clinical research, 2026
• Enpatoran in COVID‐19 pneumonia: Safety and efficacy results from a phase II randomized trial Clinical and Translational Science, 2023
• Safety and efficacy of radiotherapy combined with anlotinib in locally advanced non-small cell lung cancer patients intolerant to concurrent chemoradiotherapy: Preliminary result of a phase II clinical trial Journal of Clinical Oncology, 2025
• Belantamab mafodotin plus lenalidomide/dexamethasone in newly diagnosed intermediate-fit & frail multiple myeloma patients: Long-term efficacy and safety from the phase 1/2 BELARD clinical trial Journal of Clinical Oncology, 2025
• Prevention and treatment for COVID-19 associated severe pneumonia in the Gambia (PaTS-COVID-19), a single-blinded randomized clinical trial: study protocol International Journal of Clinical Trials, 2023
• A randomized clinical trial to evaluate the efficacy of L-carnitine L-tartrate to modulate the effects of SARS-CoV-2 infection Frontiers in Nutrition, 2023
• Efficacy and Safety Comparison of Two Different Doses of Dexamethasone in Hospitalized Patients with COVID-19: A Randomized Clinical Trial Journal of Research in Pharmacy Practice, 2023
• RAndomized Clinical Trial Of NAfamostat Mesylate, A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 Pneumonia Journal of Clinical Medicine, 2023
• Exclusive Oral Antibiotic Treatment for Hospitalized Community-Acquired Pneumonia: A Post-Hoc Analysis of a Randomized Clinical Trial Clinical Microbiology and Infection, 2024
• Efficacy and Safety of Lianhua Qingke Tablets in Children With Mycoplasma pneumoniae Pneumonia: A Randomized, Double‐Blind, Multicenter, Placebo‐Controlled Clinical Trial Clinical Respiratory Journal, 2026
• Clinical analysis of oral moxifloxacin in the treatment of outpatients with community-acquired pneumonia Central Plains Medical Journal, 2010
• Multicenter, Postmarketing Assessment of Levofloxacin in the Treatment of Adults with Community-Acquired Pneumonia Clinical Infectious Diseases, 2004
• Multicentre clinical study on levofloxacin intravenous injection for treatment of community-acquired pneumonia 2006
• Clinical and bacteriological efficacies of sitafloxacin against community-acquired pneumonia caused by Streptococcus pneumoniae: nested cohort within a multicenter clinical trial Journal of Infection and Chemotherapy, 2013
• Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study BMC neurology, 2016
• An open-label phase I/II study of cyclophosphamide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed myeloma European journal of haematology, 2015
• Consolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti-GD2 Antibody, Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-2, and Haploidentical Natural Killer Cells Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2017
• Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2020
• Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL Leukemia, 2018
• Bedaquiline for multidrug-resistant TB in paediatric patients The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2021
• Clinical effects of gemifloxacin on the delay of tuberculosis treatment Journal of Korean medical science, 2013
• Intrapulmonary Pharmacokinetics of Levonadifloxacin following Oral Administration of Alalevonadifloxacin to Healthy Adult Subjects Antimicrobial agents and chemotherapy, 2018
• Randomised controlled trial of conditioning regimen for cord blood transplantation for adult myeloid malignancies comparing high-dose cytarabine/cyclophosphamide/total body irradiation with versus without G-CSF priming: G-CONCORD study protocol BMJ open, 2020
• Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study Bone marrow transplantation, 2019
• Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders Blood advances, 2020
• An open label trial of anakinra to prevent respiratory failure in COVID-19 eLife, 2021
• Effectiveness of Xin Jia Xuan Bai Cheng Qi Decoction in treating acute exacerbation of chronic obstructive pulmonary disease: study protocol for a multicentre, randomised, controlled trial BMJ open, 2019
• Once-daily, oral levofloxacin monotherapy for low-risk neutropenic fever in cancer patients: a pilot study in China Anti-cancer drugs, 2015
• Intrapulmonary Pharmacokinetics of Lascufloxacin in Healthy Adult Volunteers Antimicrobial agents and chemotherapy, 2018
• Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial Hypertension Respiration; international review of thoracic diseases, 2017
• Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial BMC cancer, 2022
• Oral switch versus standard intravenous antibiotic therapy in left-sided endocarditis due to susceptible staphylococci, streptococci or enterococci (RODEO): a protocol for two open-label randomised controlled trials BMJ open, 2020
• Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study) American journal of hematology, 2020
• Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of Tuberculosis Antimicrobial agents and chemotherapy, 2018
• Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance BMC infectious diseases, 2021
• Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma Blood advances, 2021
• Impact of comprehensive molecular testing to reduce antibiotic use in community-acquired pneumonia (RADICAP): a randomised, controlled, phase IV clinical trial protocol BMJ open, 2020
• Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications Leukemia research, 2020
• Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial Annals of the American Thoracic Society, 2020
• CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results Nature medicine, 2023
• Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemia Blood advances, 2021
• Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analyses Trials, 2022
• Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP) Trials, 2018
• Cost-effectiveness analysis of oral versus intravenous drip infusion of levofloxacin in the treatment of acute lower respiratory tract infection in Chinese elderly patients Clinical interventions in aging, 2017
• A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial Trials, 2020
• The value of post-operative antibiotic therapy after laparoscopic appendectomy for complicated acute appendicitis: a prospective, randomized, double-blinded, placebo-controlled phase III study (ABAP study) Trials, 2020
• Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract Blood advances, 2024
• Mechanisms of Reduced Susceptibility to Cefiderocol Among Isolates from the CREDIBLE-CR and APEKS-NP Clinical Trials Microbial drug resistance (Larchmont, N.Y.), 2022
• Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial Antimicrobial agents and chemotherapy, 2022
• Study on metabonomics of Chinese herbal medicine in the treatment of type 2 diabetes mellitus complicated with community-acquired pneumonia Medicine, 2020
• Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation Leukemia, 2023
• Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial International journal of hematology, 2023
• Safety, feasibility, and impact on the gut microbiome of kefir administration in critically ill adults BMC medicine, 2024
• Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia Cancer, 2025
• Protocol of a multicenter, single-blind, randomized, parallel controlled trial evaluating the effect of microbiological rapid on-site evaluation (M-ROSE) guiding anti-infection treatment in patients with severe hospital-acquired pneumonia Trials, 2023
• Phase 1 study of talquetamab, a humanized GPRC5D x CD3 bispecific antibody, in Japanese patients with relapsed/refractory MM International journal of hematology, 2025
• Evaluation of the efficacy and safety of oral N-acetylcysteine in patients with COVID-19 receiving the routine antiviral and hydroxychloroquine protocol: A randomized controlled clinical trial Immunity, inflammation and disease, 2023
• Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK) Antimicrobial agents and chemotherapy, 2024
• Do intensive care patients need an individualized dosing regimen for levofloxacin? International journal of clinical pharmacology and therapeutics, 2006
• Clinical evaluation of oral levofloxacin 500 mg once-daily dosage for treatment of lower respiratory tract infections and urinary tract infections: a prospective multicenter study in China Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009
• An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media The Pediatric infectious disease journal, 2006
• Gatifloxacin phase IV surveillance trial (TeqCES study) utilizing 5000 primary care physician practices: report of pathogens isolated and susceptibility patterns in community-acquired respiratory tract infections Diagnostic microbiology and infectious disease, 2002
• Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1998
• Efficacy of levofloxacin (Tavanic) in the treatment of children with chronic pulmonary diseases Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2004
• Levofloxacin in the treatment of community-acquired pneumococcal pneumonia Presse medicale (Paris, France : 1983), 1999
• Ceftriaxone to PRevent pneumOnia and inflammaTion aftEr Cardiac arresT (PROTECT): study protocol for a randomized, placebo-controlled trial Trials, 2022
• Efficacy of osteopathic manipulation as an adjunctive treatment for hospitalized patients with pneumonia: a randomized controlled trial Osteopathic Medicine and Primary Care, 2010
• Efficacy of Perilla frutescens (L.) Britton var. frutescens extract on mild knee joint pain: A randomized controlled trial Frontiers in Pharmacology, 2023
• Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial Trials, 2020
• Inhaled antibiotics for treating pneumonia in invasively ventilated patients in intensive care unit: a meta-analysis of randomized clinical trials with trial sequential analysis Critical Care, 2024
• Adjunctive intravenous then oral vitamin C for moderate and severe community-acquired pneumonia in hospitalized adults: feasibility of randomized controlled trial Scientific Reports, 2023
• Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial American Journal of Respiratory and Critical Care Medicine, 2022
• Efficacy and safety of a decision rule for using antibiotics in children with pneumonia and vaccinated against pneumococcus. A randomized controlled trial Archivos Argentinos de Pediatria, 2015
• Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial Critical Care, 2020
• The Safety and Efficacy of Inspiratory Muscle Training for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Study Protocol for a Randomized Controlled Trial Frontiers in Cardiovascular Medicine, 2021
• Efficacy of Kegan Liyan oral liquid vs. Lianhuaqingwen capsules for patients with mild COVID-19: a double-blinded, randomized, controlled, non-inferiority trial Frontiers in Medicine, 2025
• The safety and efficacy of Chinese herbal medicine for pneumonia prevention in high-risk elder residents in the nursing home: A randomized, double-blind clinical trial Journal of Ethnopharmacology, 2023
• The safety and efficacy of stem cells for the treatment of severe community-acquired bacterial pneumonia: A randomized clinical trial Journal of critical care, 2023
• The effect and safety of corticosteroid treatment for severe community-acquired pneumonia: a meta-analysis of randomized controlled trials Frontiers in Medicine, 2024
• Randomized, controlled trial comparing Rhodococcus equi and poly‐N ‐acetyl glucosamine hyperimmune plasma to prevent R equi pneumonia in foals Journal of Veterinary Internal Medicine, 2021
• Efficacy and safety of Andrographis paniculata extract in patients with mild COVID-19: A randomized controlled trial medRxiv, 2021
• Safety and efficacy of N-acetyl-cysteine for prophylaxis of ventilator-associated pneumonia: a randomized, double blind, placebo-controlled clinical trial Medical Gas Research, 2018
• Addition of probiotics to antibiotics improves the clinical course of pneumonia in young people without comorbidities: a randomized controlled trial Scientific Reports, 2021
• High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial Cureus, 2021